Signing out of account, Standby...
Patrick Ryan - Page 6
With a new administration, investors can be less concerned with Chinese companies getting delisted from U.S. exchanges. This makes it a great time to consider stocks from China. Tal Education Group (TAL) and Yum China Holdings (YUMC) are two top companies in China, but which is a better now now? Read more to find out.
Zscaler (ZS) and McAfee (MCFE) are two cybersecurity stocks that investors should consider. In 2020, ZS was an outperformed, while MCFE has grabbed the baton this year. Which of these is the better buy?.
The video game industry exploded during the COVID-19 pandemic. That growth isn't expected to slow anytime soon, with generations Y and Z hooked on games. Three gaming stocks that investors should keep an eye on are Nintendo (NTDOY), Playtika Holding (PLTK), and Gravity (GRVY). Read more to learn why.
The proprietary POWR Ratings system is calculated daily based on 118 factors. Stocks that rated a Strong Buy have proven to outperform the market, which is why investors should keep a close on on recent upgrades. Patrick Ryan highlights three recent Strong Buy upgrades: Foot Locker (FL), Kohl's Corporation (KSS), and Nathan's Famous (NATH).
The stock market's character has changed in 2021. For investors, it means they need to be even more selective and carefully assess their own holdings. Ashford Hospitality Trust (AHT), Ideal Power (IPWR), and Viad (VVI) are 3 downgraded stocks that investors should avoid.
Clover (CLOV) and Centene (CNC) are two companies that offer healthcare plans to customers. CLOV has been in the headlines due to its high-profile investors, while CNC is lesser-known. Patrick Ryan explains why CNC is the better buy.
Due to restrictions driven by the COVID-19 pandemic, people adopted a variety of new hobbies, including off-roading. Two stocks that have benefited from this trend are Polaris (PII) and Fox Factory Holding Corp. (FOXF). But which is the better Buy now? Read more to find out.
Healthcare companies are continuously looking for new treatment options for patients. One in particular, COMPASS Pathways (CMPS), is focused on using psilocybin therapy treat depression. The stock has generated a lot of interest, but is down 25% for the year. Is it time to buy? Read more to find out.
The Trade Desk’s (TTD) stock declined more than 25% in a single day following the company's latest earnings report. Because the stock dipped 50% below its yearly high, it could be a fantastic buying opportunity for investors who have been patiently waiting on the sidelines. So, is TTD worthy of their investing dollars now that it is available at a considerable discount? Read on for an answer.
Facebook (FB) continues to broaden its horizons by diversifying its revenue streams across social media, virtual reality, online transactions and possibly even its own cryptocurrency at some point in the future. Though the stock has gyrated this month, top analysts are bullish on the name in-part due to its diversified revenue streams. So, is the stock an attractive buy now in the wake of a post-earnings report dip? Read on to find out.
The increasing popularity of consumer electronics in general, along with the ongoing rollout of 5G networks, have been driving up the demand for semiconductors amid a global shortage of the commodity. Broadcom (AVGO) and Micron Technology (MU) are two leaders in semiconductor production space that we think deserve a second look by investors amid the supply/demand imbalance. But let’s find out which of these stocks is a better buy now.
Qorvo (QRVO) and Lam Research Corporation (LRCX) were two stocks that have experienced steep corrections in recent weeks. However, there are signs that the selling pressure may relax and we could see a bounce in certain semiconductor stocks.
Biotech and pharmaceutical stocks have come to the forefront due to the pandemic. ChemoCentryx (CCXI) aims to provide therapies to combat cancer, autoimmune diseases, and inflammatory disorders, but is it a buy? Read more to find out.